C030039L03Rik Inhibitors
C030039L03Rik, a product of the RIKEN cDNA C030039L03 gene, intricately participates in cellular processes, potentially involving gene expression regulation. While direct inhibitors for C030039L03Rik remain elusive, exploration of potential inhibitors targeting key signaling pathways reveals promising avenues for further investigation.
Functionally, C030039L03Rik is intricately linked to the PI3K-AKT, mTOR, GSK-3, JNK, and MAPK pathways. These pathways collectively contribute to cellular responses and gene expression dynamics associated with C030039L03Rik. The identified inhibitors, such as LY294002, Rapamycin, and SB216763, target these pathways to potentially impact the regulatory mechanisms and gene expression dynamics associated with C030039L03Rik. The PI3K-AKT pathway, vital for cellular survival and proliferation, mTOR pathway crucial for cellular growth, GSK-3 signaling, JNK pathway modulating stress responses, and MAPK pathway influencing various cellular processes collectively contribute to the intricate role of C030039L03Rik in cellular homeostasis. The identified inhibitors modulate these pathways, providing a foundation for future investigations into the regulatory intricacies of C030039L03Rik and its potential modulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, disrupts the PI3K-AKT pathway, potentially influencing cellular processes linked to C030039L03Rik. Its impact on the regulatory mechanisms of this enigmatic protein could lead to alterations in gene expression dynamics. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, may indirectly impact C030039L03Rik by targeting mTOR-dependent cellular processes, potentially altering the landscape of gene expression and the regulatory mechanisms associated with this protein. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, may indirectly influence C030039L03Rik by suppressing c-Jun N-terminal kinase activity, impacting gene expression dynamics associated with this enigmatic protein through modulation of cellular stress responses. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB216763, a GSK-3 inhibitor, may influence C030039L03Rik by disrupting GSK-3 signaling, impacting downstream cellular responses and potentially altering gene expression dynamics associated with this enigmatic protein. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
MK-2206, an allosteric AKT inhibitor, may intricately influence cellular processes associated with C030039L03Rik by modulating the PI3K-AKT pathway. Its impact on the regulatory mechanisms of this enigmatic protein could lead to alterations in gene expression dynamics. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $245.00 | 7 | |
Torin 1, a dual mTOR inhibitor, may indirectly impact C030039L03Rik by targeting mTOR-dependent cellular processes, potentially altering the landscape of gene expression and the regulatory mechanisms associated with this protein. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, acting as a p38 MAP kinase inhibitor, may indirectly influence C030039L03Rik by altering the dynamics of cellular responses crucial for this enigmatic protein through modulation of the MAPK pathway, particularly p38 MAP kinase. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, disrupts the PI3K-AKT pathway, potentially influencing cellular processes linked to C030039L03Rik. Its impact on the regulatory mechanisms of this enigmatic protein could lead to alterations in gene expression dynamics. | ||||||
AZD2014 | 1009298-59-2 | sc-364420 | 5 mg | $303.00 | 2 | |
AZD8055, a dual mTOR inhibitor, may indirectly impact C030039L03Rik by targeting mTOR-dependent cellular processes, potentially altering the landscape of gene expression and the regulatory mechanisms associated with this protein. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132, a JNK inhibitor, may indirectly influence C030039L03Rik by suppressing c-Jun N-terminal kinase activity, impacting gene expression dynamics associated with this enigmatic protein through modulation of cellular stress responses. | ||||||